These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2113298

  • 21. [Experimental studies on the effect of perfluorochemicals in tumor irradiation].
    Shinoda J, Iwai T, Hattori T, Kondo H, Sakai N, Yamada H.
    Gan No Rinsho; 1984 Jan; 30(1):53-8. PubMed ID: 6700116
    [Abstract] [Full Text] [Related]

  • 22. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
    Teicher BA, Holden SA, Crawford JM.
    Cancer; 1988 Jun 01; 61(11):2196-201. PubMed ID: 3365649
    [Abstract] [Full Text] [Related]

  • 23. Increase in tumor pO2 by perfluorochemicals and carbogen.
    Hasegawa T, Rhee JG, Levitt SH, Song CW.
    Int J Radiat Oncol Biol Phys; 1987 Apr 01; 13(4):569-74. PubMed ID: 3104250
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A, Menke D, Dorie MJ, Brown JM.
    Radiat Oncol Investig; 1999 Apr 01; 7(3):163-9. PubMed ID: 10406058
    [Abstract] [Full Text] [Related]

  • 25. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
    Teicher BA, Dupuis NP, Robinson MF, Kusumoto T, Liu M, Menon K.
    In Vivo; 1994 Apr 01; 8(1):125-31. PubMed ID: 8054502
    [Abstract] [Full Text] [Related]

  • 26. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type.
    Okajima K, Griffin RJ, Iwata K, Shakil A, Song CW.
    Radiat Res; 1998 Mar 01; 149(3):294-9. PubMed ID: 9496893
    [Abstract] [Full Text] [Related]

  • 27. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
    Teicher BA, Holden SA.
    Cancer Treat Rep; 1987 Feb 01; 71(2):173-7. PubMed ID: 3100035
    [Abstract] [Full Text] [Related]

  • 28. Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy.
    Koutcher JA, Alfieri AA, Kornblith AB, Devitt ML, Cowburn D, Ballon D, Kim JH.
    Cancer Res; 1990 Nov 15; 50(22):7252-6. PubMed ID: 2121332
    [Abstract] [Full Text] [Related]

  • 29. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA, Crawford JM, Holden SA, Cathcart KN.
    Cancer Res; 1987 Oct 01; 47(19):5036-41. PubMed ID: 3113727
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity.
    Thomas C, Riess J, Guichard M.
    Int J Radiat Biol; 1991 Feb 01; 59(2):433-45. PubMed ID: 1671693
    [Abstract] [Full Text] [Related]

  • 32. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
    Kim GE, Song CW.
    Cancer Chemother Pharmacol; 1989 Feb 01; 25(2):99-102. PubMed ID: 2513138
    [Abstract] [Full Text] [Related]

  • 33. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
    Teicher BA, Holden SA, Rose CM.
    J Natl Cancer Inst; 1985 Dec 01; 75(6):1129-33. PubMed ID: 3934448
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
    Rojas A, Joiner MC, Hodgkiss RJ, Carl U, Kjellen E, Wilson GD.
    Int J Radiat Oncol Biol Phys; 1992 Dec 01; 23(2):361-6. PubMed ID: 1587757
    [Abstract] [Full Text] [Related]

  • 35. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
    Holden SA, Herman TS, Teicher BA.
    Radiother Oncol; 1990 May 01; 18(1):59-70. PubMed ID: 2113698
    [Abstract] [Full Text] [Related]

  • 36. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR, Overgaard J.
    Radiother Oncol; 2004 Mar 01; 70(3):301-9. PubMed ID: 15064017
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH, Mang TS, Henderson BW.
    Cancer Res; 1988 Jun 15; 48(12):3350-4. PubMed ID: 3130983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.